Distinguished breast cancer expert, Dr. George W. Sledge, Jr., M.D., joins our Board
Tessa Therapeutics announced that Dr. George W. Sledge, Jr., M.D., Professor and Chief of Medical…
Continue Reading
-
-
Tessa Therapeutics Appoints Dr. Ivan Horak as President of Research and Development
Tessa Therapeutics, a clinical stage biopharmaceutical company focusing on cellular immunotherapy treatments for cancer, today…
Continue Reading -
St. Jude Children’s Research Hospital and Tessa Therapeutics Announce Strategic Collaboration
St. Jude Children’s Research Hospital (St. Jude), the U.S. hospital leading the way the world…
Continue Reading -
Tessa Therapeutics announces new Board Member and increase of recent funding round
Tessa Therapeutics is delighted to announce that Göran Ando, the former Chairman of Novo Nordisk…
Continue Reading -
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nose Cancer Immunotherapy Trial
With the Stanford Cancer Institute joining as a clinical trial partner, Tessa’s Phase III trial…
Continue Reading